Lili Reinhart has shared that she has been diagnosed with endometriosis. The Riverdale actor spoke about her experience on Instagram, explaining that the diagnosis came after she underwent laparoscopic surgery.

Reinhart wrote that last year she consulted a urogynecologist and was diagnosed with interstitial cystitis, a condition she was told has no cure and offers little long-term relief. She described multiple hospital visits and appointments with different urologists and gynaecologists, noting that none of them seriously explored endometriosis as a possible cause of her symptoms during that time.

Lili Reinhart Diagnosed with Endometriosis After Doctors Dismissed Her Pain

Lili Reinhart has said she was finally diagnosed with endometriosis after months of feeling unheard by doctors.

On Thursday, December 11, the Riverdale star shared images from her hospital stay on Instagram, including photos of her abdomen following laparoscopic surgery. The 29 year old revealed that she received her endometriosis diagnosis last week. The condition occurs when tissue similar to the uterine lining grows outside the uterus, often leading to severe cramps and long term pelvic pain.

In her post, Reinhart explained that last year she visited a urogynecologist and was diagnosed with interstitial cystitis. She was told there was no cure and little chance of lasting relief. She recalled three hospital visits and appointments with several urologists and gynecologists, none of whom seriously looked at endometriosis as the possible cause of her symptoms.

She added that it was only after working with two pelvic floor therapists that endometriosis was even raised as a potential reason for her pain. Reinhart said she then requested an MRI herself, which led to a diagnosis of adenomyosis, a form of endometriosis that affects the uterus.

She went on to share that while an endometriosis specialist supported her decision to undergo laparoscopic surgery, another gynecologist dismissed the possibility of endometriosis and suggested she simply start birth control pills instead.

Lili Reinhart: What Is Endometriosis?

Endometriosis is a chronic condition in which tissue similar to the lining of the uterus begins to grow outside the uterus. These growths most commonly affect the ovaries, fallopian tubes, and the tissue lining the pelvis. In rare cases, the tissue may spread beyond the pelvic organs.

Like the uterine lining, this misplaced tissue responds to hormonal changes during the menstrual cycle. It thickens, breaks down, and bleeds each month. However, because it has no way to exit the body, it can lead to inflammation and irritation in surrounding areas. When the ovaries are involved, fluid filled cysts known as endometriomas can develop. Over time, scar tissue and fibrous bands called adhesions may form, causing pelvic organs to stick together.

Lili Reinhart Endometriosis: Symptoms You Should Know

Pelvic pain is the most common symptom of endometriosis and is often linked to menstruation. While period cramps are common, people with endometriosis usually report pain that is more intense than usual and tends to worsen over time.

Common symptoms include:

• Painful periods: Cramping and pelvic pain may begin before menstruation and continue for several days. Lower back and abdominal pain are also common. This is known as dysmenorrhea.
• Pain during or after sex: Discomfort with intercourse is frequently reported.
• Pain during bowel movements or urination: These symptoms are more likely to occur just before or during periods.
• Heavy or irregular bleeding: This may include very heavy periods or bleeding between cycles.
• Infertility: In some cases, endometriosis is only discovered during investigations for difficulty conceiving.
• Other symptoms: Fatigue, bloating, nausea, diarrhea, or constipation, particularly around menstruation.

The intensity of pain does not always reflect how advanced the condition is. Some people experience severe pain with minimal tissue growth, while others may have extensive endometriosis with little or no discomfort.

Anti-pollution measures under GRAP-3 came into force in Delhi on Saturday as air quality slipped into the “severe” bracket. By noon, the national capital reported an Air Quality Index of 405, according to figures released by the Central Pollution Control Board (CPCB). Earlier in the day, Delhi’s AQI hovered close to 390 during the morning hours.

Delhi Air Quality Hits ‘Severe'

Each winter, Delhi and the surrounding NCR (National Capital Region) bring in curbs under the Graded Response Action Plan, which divides air quality into four levels: Stage 1 (Poor, AQI 201–300), Stage 2 (Very Poor, AQI 301–400), Stage 3 (Severe, AQI 401–450) and Stage 4 (Severe Plus, AQI above 450).

Under GRAP-3, non-essential construction and demolition activities have been halted, along with stone crushing and mining operations. The measures also include restrictions on older diesel goods vehicles within Delhi. Schools up to Class 5 are required to move to a hybrid learning model, while offices across Delhi-NCR may function with only 50 per cent staff strength, as per Press Information Bureau.

Hazardous AQI levels have become a recurring feature across several parts of Delhi during the winter months. Quoting environmental experts, an IANS report linked the sharp decline in air quality to a mix of stagnant wind conditions, vehicle emissions, industrial pollution and seasonal factors such as crop residue burning in neighbouring states.

What Changed in GRAP?

The biggest shift under the updated GRAP framework is that stricter steps will now come into force earlier, instead of waiting for air quality to deteriorate further.

As per Press Information Bureau, under the revised system, measures that were earlier reserved for Stage 4 will now apply at Stage 3 itself. This means that once the AQI reaches the 301–400 range, public, municipal and private offices will function with only 50 percent staff. Central government offices will also move to work-from-home at this stage, rather than waiting for the AQI to cross 450.

In the same way, actions that earlier fell under Stage 3 have now been pushed to Stage 2. As a result, staggered timings for government offices will begin as soon as the AQI enters the 201–300 category.

Stage 2 measures have also been advanced to Stage 1. This brings uninterrupted power supply arrangements into effect earlier, at an AQI level of 101–200, to reduce the need for diesel generator use and limit additional emissions.

Delhi AQI: GRAP Stage 3 Restrictions Announced

In response to the worsening situation, the Delhi government confirmed that the Commission for Air Quality Management (CAQM) has activated all measures under Stage III of GRAP, which falls under the “Severe” air quality category with AQI levels between 401 and 450, across the entire NCR.

These Stage 3 curbs will apply in addition to the existing Stage I and Stage II measures. Authorities, including NCR Pollution Control Boards, have been instructed to step up enforcement to prevent further deterioration of air quality across the region.

• Ban on the transportation of construction materials such as sand and cement, particularly on non-paved roads
• Complete suspension of demolition and construction work unless unavoidable, including earthwork, piling and trenching
• Advisory for private firms to permit work-from-home or hybrid arrangements to reduce traffic-related pollution
• Restrictions on inter-state diesel buses entering or operating within Delhi
• Prohibition on BS-3 petrol and BS-4 diesel four-wheelers in Delhi and nearby NCR districts
• Shutdown of stone crushers, mining operations and hot-mix plants that do not run on clean fuel
• Ban on the use of diesel generator sets, except for emergency and essential services

GRAP III Imposed in Delhi-NCR: What’s Allowed

Even as Stage III of the Graded Response Action Plan comes into force, certain essential activities and services will continue to operate to minimise disruption to daily life.

• Essential infrastructure and public service projects permitted include:
• Metro, railway, airport, highway, defence, healthcare and sanitation-related projects
• Construction work linked to critical infrastructure, provided strict dust control and proper waste management norms are followed
• Vehicles used by persons with disabilities
• Recommended measures under GRAP III include:
• Greater use of public transport to reduce private vehicle emissions
• Hybrid or online classes for students up to Grade 5 to limit outdoor exposure and traffic movement

The U.S. Food and Drug Administration has cleared an at-home brain stimulation headset developed by Flow Neuroscience to help treat depression, giving patients another option beyond standard antidepressant drugs, which many people struggle to stay on because of long-term side effects, the company announced on Thursday.

Rates of depression in the U.S. have climbed sharply, rising by about 60% over the past ten years and now affecting more than 20 million adults, according to data from the Centers for Disease Control and Prevention.

FDA Approves First At-Home Brain Stimulation Device For Treatment of Depression

The US Food and Drug Administration (FDA) has approved a home-use brain stimulation device designed to treat major depressive disorder in adults. The device, known as FL-100 and made by Flow Neuroscience, is the first at-home treatment of its kind to receive approval in the United States.

The FDA’s decision was supported by results from the Empower phase 2 clinical trial, which found that 58% of participants reached remission after 10 weeks of treatment. Flow Neuroscience also reported that among users worldwide, 77% noticed an improvement in symptoms within three weeks. To date, more than 55,000 patients have used the device in regions including Europe, the UK, Switzerland, and Hong Kong.

Brain Stimulation Device For Depression: How Will The Headset Work?

The prescription device, called FL-100, uses transcranial direct current stimulation to send a mild electrical current to the brain’s prefrontal cortex, an area involved in mood control and stress response. According to Flow, this part of the brain is often less active in people living with depression, a condition that affects over 20 million adults across the U.S.

Flow noted that roughly one in three people with depression does not respond adequately to antidepressant medications, and many others discontinue them because of unwanted side effects.

“Flow’s FDA approval marks a turning point in depression care, representing the first real move away from medication-only treatment toward technology-based therapies with fewer side effects,” said Flow CEO Erin Lee in a statement.

During the study, participants wore the headset for 30 minutes per session while resting, beginning with five sessions a week for the first three weeks, then reducing to three sessions per week for the rest of the trial. The program also included live remote monitoring through video calls.

Researchers observed benefits in patients who were already taking antidepressants for treatment-resistant depression or receiving psychotherapy, as well as in those who were not using medication at all.

“Among people using Flow in real-world settings, 77% report feeling better in as little as three weeks,” said Kultar Garcha, M.D., chief medical officer at Flow. “A treatment that was once limited to clinics can now be used at home, offering a practical way to widen access to effective depression care.”

Flow said it plans to launch the headset commercially in the U.S. in the second quarter of next year and intends to explore its potential use for conditions such as traumatic brain injury, addiction, and sleep disorders.

“We want Flow to become part of the standard pathway for treating depression,” Lee said. “Our focus is clear: to help as many people as possible reach remission and regain their quality of life.”

King Charles has delivered what he described as “good news” about his cancer, saying that early detection and timely treatment mean his care can now be scaled back in the coming year.

In a recorded message aired on Channel 4 as part of the Stand Up To Cancer appeal, the King spoke openly about his experience. “This moment feels both deeply personal and a reflection of how far cancer treatment has come,” he said, pointing to advances in care that have shaped his recovery.

It is the most detailed update on his condition since he publicly confirmed his diagnosis in February 2024.

King Charles's Cancer: What Kind Of Cancer Does King Charles Have?

The Palace has not disclosed the specific type of cancer, and officials have said treatment and monitoring will continue. What has been confirmed is that the King’s progress has been strong. Buckingham Palace said he has responded “exceptionally well” and has now entered what doctors describe as a precautionary phase of care.

As a result, the frequency of his treatment will be significantly reduced. However, the King, who is 77, has not been described as being cured or in remission.

“Thanks to early diagnosis, effective intervention and following my doctors’ advice, my treatment schedule can be reduced in the new year,” he said in his address.

The video, recorded at Clarence House two weeks earlier, was broadcast during Friday night’s Stand Up To Cancer programme, a fundraising initiative supported by Cancer Research UK.

The campaign aims to encourage people to come forward for testing and use national screening programmes. In his message, the King stressed how vital early checks can be.

He reflected on the emotional weight of a diagnosis, saying it can feel overwhelming. At the same time, he underlined that catching cancer early can change outcomes by giving doctors more time and options. “Early detection can save lives,” he said. “It may save your life, or the life of someone you love.”

King Charles's Health Update

On January 17, 2024, Buckingham Palace announced that the King would undergo a corrective procedure for a benign enlarged prostate, a common condition associated with ageing. He was advised to take a short period of rest following the treatment.

The procedure took place at the London Clinic private hospital on January 26, and he was discharged three days later, on January 29.

Dr Otis Brawley, a professor of oncology and associate director of outreach and engagement at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, told TODAY.com that benign prostate enlargement is a frequent and non-cancerous condition seen in older men.

What Is Prostate Cancer?

Prostate cancer develops when cells in the prostate begin to grow and divide in an uncontrolled way. The prostate is a small gland in the male reproductive system that produces seminal fluid and sits just below the bladder, as per Mayo Clinic.

In many cases, the disease progresses slowly and may not cause noticeable symptoms in its early stages. When it advances or spreads to other parts of the body, it can lead to urinary problems such as frequent urination, a weak or burning stream, erectile difficulties, and pain in the lower back or hips. Diagnosis usually involves PSA blood tests and tissue biopsies, and the majority of cases are adenocarcinomas that respond well to treatment when caught in time.